Follow us on LinkedIn for the very latest news and updates!
Latest news
New pre-print! A Controlled Human Malaria Infection model for relapsing Plasmodium vivax
25 June 2026
Gates Foundation Grand Challenges Annual Meeting 2026
22 June 2026
Gyrolab User Seminar - best presenter prize, Sarah!
16 June 2026
Scientists in the Department of Paediatrics discover antibody combinations that block over 90% of malaria parasite growth
12 June 2026
Millie Gladstone recognised for excellence in research methodology
10 June 2026
A broadly-neutralizing antibody against Orthoebolavirus glycoprotein that potentiates the breadth and neutralization of other antibodies
12 May 2026
World Vaccine Congress 2026: Antibody Innovation in Full Bloom
30 April 2026
University of Oxford and Serum Institute of India agree licence to advance the next-generation multi-stage malaria vaccine candidate component
25 April 2026
Angela, Sarah and Shivani visit the MVC/UVRI and LSHTM Uganda Research Unit
24 April 2026
Jennifer presents at ESCMID Global 2026
23 April 2026
Anika's poster presentation at EMBO | EMBL Symposium and BSI's annual Oxford Immunology Symposium
03 April 2026
Simon Guest Speaker at Medawar Day
06 March 2026
Infectious Disease Epidemiology Unit (IDEU) Symposium talk given by Simon
04 March 2026
R21 and RH5.1 cellular immunology in endemic settings published in Frontiers in Immunology
02 March 2026
New clinical trials begin in Burkina Faso
23 February 2026
Simon invited speaker at the 6th Singapore Malaria Network (SingMalNet) Meeting 2026
12 February 2026
New preprint! Structural basis for synergistic antibody protection against the essential malaria invasion complex protein RIPR
12 January 2026
B cell meeting at Pirbright Institute
16 December 2025
Global Consortium Launched to Develop Next-Generation Malaria Vaccine
08 December 2025
Jo presents at the Federation of Infection Societies conference in Bournemouth
05 December 2025
LEGACY IIII Network Launch in Liverpool
02 December 2025
Draper Group members attend the Annual Meeting of the American Society of Tropical Medicine and Hygiene (ASTMH) in Toronto
17 November 2025
Introducing our new Associate Heads of Department
10 November 2025
Simon attends the 11th National Infection Biology (NIB) Meeting and three-day Vaccinology Course in Sweden
22 October 2025
Congratulations to Dr Mimi Hou
10 October 2025
Parafrap 2025 Île des Embiez
06 October 2025
7th HIC-Vac Annual Meeting at Keble College, Oxford & Best poster prize winner, Millie!
01 October 2025
New Article Published in Nature Communications: 'Development of clinical immunity to Plasmodium vivax following repeat controlled human malaria infection'
25 September 2025
Oxford Vaccine Group Away Day at the Mathematical Institute
19 September 2025
Simon participates in AoPGBI (Association of Physicians of Great Britain and Ireland) Webinar Series on Emerging Issues in Medicine
05 September 2025
Millie presents at the Antibodies and Complement Conference in Catania, Sicily
06 June 2025
OptiViVax Consortium Annual Meeting 2025 in Cork, Ireland
05 June 2025
BioMalPar XXI Conference in Heidelberg
21 May 2025
Professor Simon Draper elected Fellow of the Academy of Medical Sciences
22 May 2025
Watch Prof Angela Minassian in the Natural History Museum Oxford on World Malaria Day 25 April 2025
25 April 2025
Simon gives plenary talk at the Japanese Society of Parasitology conference in Osaka
24 March 2025
Mimi presents at the 9th International Conference on Plasmodium vivax Research (ICPvR) in India
17 February 2025
Naked Scientist talks to Andrew Duncan about new malaria trial
05 February 2025
BIO-006 study featured in BBC news coverage
23 January 2025
Annual meeting of the EDCTP Multi-Stage Malaria Vaccine Consortium (MMVC)
09 January 2025
Trial results for first vaccine against blood-stage malaria show it is well-tolerated and offers effective protection
11 December 2024
Annual Meeting of the American Society of Tropical Medicine and Hygiene (ASTMH) in New Orleans, USA
15 November 2024
Malaria: Past, Present and Future
12 November 2024
Simon's plenary talk at the International Society for Vaccines (ISV) Annual Congress 2024 in Seoul
21 October 2024
Malaria vaccine RH5.1/Matrix-M is effective in preventing malaria in African children (new preprint)
22 October 2024
New paper "Analysis of the diverse antigenic landscape of the malaria protein RH5 identifies a potent vaccine-induced human public antibody clonotype" published in Cell
26 July 2024
New paper published in Cell Reports Medicine
23 July 2024
Draper Group members attend UK Clinical Vaccine Network Annual Conference in Birmingham
13 June 2024
Now published in The Lancet ID - Phase Ib clinical trial of our most advanced malaria vaccine candidate, RH5.1 in Matrix-M.
17 June 2024
Now published in Nature Communications - Development of an improved blood-stage malaria vaccine targeting the essential RH5-CyRPA-RIPR invasion complex
07 June 2024
Carolyn and Andrew interview on Radio Cherwell re ongoing recruitment for malaria challenge trials
24 May 2024
Now published in Vaccine: Analysis of the precision of the transgenic P. knowlesi growth inhibition assay for P. vivax vaccine development
15 May 2024
Multilateral Initiative on Malaria (MIM) Society 8th Pan-African Malaria Conference
22 April 2024
New preprint: Phase Ib clinical trial of our leading malaria vaccine candidate, RH5.1 in Matrix-M, conducted in Tanzania
02 April 2024
Advancing a malaria vaccine for better global health outcomes - Press Release
20 March 2024
New trial to study how the human immune system adapts to 'tolerate' malaria parasites
19 March 2024
New preprint on the development of an improved blood-stage malaria vaccine
13 February 2024
Oxford Cytometry Club Meeting
08 February 2024
Paper published in Frontiers in Immunology
17 January 2024
Behind the scenes: developing a new malaria vaccine - Oxford Sparks
24 November 2023
Teaching excellence project award for Susanne, Fran, and Barney
10 November 2023
Inaugural Richard J. Meyer Endowed Lecture at UTA
17 October 2023
Grand Challenges Annual Meeting (GCAM) 2023
09 October 2023
Results from the first RH5 candidate vaccine trial in a malaria-endemic setting, VAC070 published in Med
11 August 2023
Results from P. vivax vaccine efficacy trials VAC071 and VAC079 published in Science Translational Medicine
20 July 2023
LEAF Silver Award for the Draper Lab!
12 July 2023
Ebola mAbs review
07 July 2023
Malaria GRC
30 May 2023
Spring 2023 Oxford/Pirbright B cell meeting
05 May 2023
Jo Salkeld features in photoshoot for Telegraph to mark World Malaria Day
28 April 2023
EDCTP MIMVaC-Africa Consortium 2023
17 January 2023
10th Anniversary Symposium of the Vaccine Formulation Institute (VFI)
27 April 2023
VAC086 Trial: Sarah sets up laboratory and conducts training at Fajara station in The Gambia
27 April 2023
Dr Jee-Sun Cho & the VAC089 study featured by the NIHR for World Malaria Day
22 April 2023
Unveiling our new Carterra LSA
13 February 2023
Delayed fractional dosing clinical immunology paper published in JCI Insight
02 February 2023
VAC063C Clinical trial paper published in Frontiers in Immunology
16 December 2022
EDCTP Multi-Stage Malaria Vaccine Consortium (MMVC) annual meeting in The Gambia
22 November 2022
Annual Meeting of the American Society of Tropical Medicine and Hygiene (ASTMH) in Seattle
03 November 2022
ICTMM2020 Bangkok
25 October 2022
National Institute of Allergy and Infectious Diseases (NIAID) Malaria Research Program (MRP) Symposium
06 October 2022
20th Protein Island Matsuyama International Symposium (PIM2022), Matsuyama, Ehime, Japan
16 September 2022
11th Infectious Diseases in Africa (IDA) Symposium in Stellenbosch, South Africa
08 September 2022
UK Clinical Vaccine Network Meeting 30 June 2022
06 July 2022
Fran presenting at Keystone Symposium - Antibodies As Drugs 2022
23 May 2022
Carolyn attends Keystone Symposium in Hanover, Germany
02 May 2022
First UK B cell meeting
27 April 2022
World Malaria Day 2022
25 April 2022
8th International Conference on Plasmodium vivax Research 2022 (ICPvR)
12 April 2022
Draper Group at the BSP Spring Meeting 2022
25 March 2022
Malaria Vaccine R&D Webinar - GVIRF 2022
03 March 2022
New paper describes a novel mechanism for antibody synergy against a malaria vaccine candidate
22 February 2022
Angela Minassian: The Malaria Researcher Leading the COVID Vaccine Trials
22 February 2022
Listen to our clinical lead in this latest 'Malaria under the microscope' podcast
3Rs Commendation for Draper Group
21 January 2022
COVID-19 Vaccine Team Receive Award at 2021 RSPH Awards Ceremony
22 October 2021
Draper group establishes high quality infection model for Plasmodium vivax
08 October 2021
New paper shedding light on the (lack of) interaction between human basigin and SARS-CoV-2 spike
17 September 2021
New study supports RH5 vaccine trials in malaria-endemic regions
29 June 2021
Latest RH5 clinical trial shows promise
28 April 2021
Our latest clinical trial publication is now out!
Revealing the immunological detail of protein and viral vector vaccine responses
28 April 2021
Our new paper examines the immune response to two different vaccine platforms
Ebola mAbs on Radio Cherwell
15 February 2021
An interview with our own Fran about her work on Ebola mAbs
Working in COVID-19 research: running a vaccine study
30 January 2021
An interview with Dr Angela Minassian on leading a COVID-19 trial